{"id":"https://openalex.org/W2970050461","doi":"https://doi.org/10.1002/psp4.12461","title":"A Physiologically\u2010Based Pharmacokinetic Model for the Prediction of Monoclonal Antibody Pharmacokinetics From In Vitro Data","display_name":"A Physiologically\u2010Based Pharmacokinetic Model for the Prediction of Monoclonal Antibody Pharmacokinetics From In Vitro Data","publication_year":2019,"publication_date":"2019-08-29","ids":{"openalex":"https://openalex.org/W2970050461","doi":"https://doi.org/10.1002/psp4.12461","mag":"2970050461","pmid":"https://pubmed.ncbi.nlm.nih.gov/31464379","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6813168"},"language":"en","primary_location":{"id":"doi:10.1002/psp4.12461","doi":"https://doi.org/10.1002/psp4.12461","is_oa":true,"landing_page_url":"https://doi.org/10.1002/psp4.12461","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/psp4.12461","source":{"id":"https://openalex.org/S4210231731","display_name":"CPT Pharmacometrics & Systems Pharmacology","issn_l":"2163-8306","issn":["2163-8306"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CPT: Pharmacometrics & Systems Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/psp4.12461","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016745322","display_name":"Hannah M. Jones","orcid":"https://orcid.org/0000-0003-2711-4545","observed_orcids":["https://orcid.org/0000-0003-2711-4545"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Hannah M. Jones","raw_affiliation_strings":["BioMedicine Design, Pfizer Worldwide R&D, Cambridge, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMedicine Design, Pfizer Worldwide R&D, Cambridge, Massachusetts, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100347603","display_name":"Zhiwei Zhang","orcid":"https://orcid.org/0000-0002-6131-3233","observed_orcids":["https://orcid.org/0000-0002-6131-3233"]},"institutions":[{"id":"https://openalex.org/I4210137149","display_name":"Renewable Energy Systems (United States)","ror":"https://ror.org/036gc1b60","country_code":"US","type":"company","lineage":["https://openalex.org/I4210090535","https://openalex.org/I4210137149"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhiwei Zhang","raw_affiliation_strings":["RES Group Inc, Needham, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RES Group Inc, Needham, Massachusetts, USA","institution_ids":["https://openalex.org/I4210137149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059392154","display_name":"Paul Jasper","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137149","display_name":"Renewable Energy Systems (United States)","ror":"https://ror.org/036gc1b60","country_code":"US","type":"company","lineage":["https://openalex.org/I4210090535","https://openalex.org/I4210137149"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Jasper","raw_affiliation_strings":["RES Group Inc, Needham, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RES Group Inc, Needham, Massachusetts, USA","institution_ids":["https://openalex.org/I4210137149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076437039","display_name":"Haobin Luo","orcid":"https://orcid.org/0000-0002-6497-0159","observed_orcids":["https://orcid.org/0000-0002-6497-0159"]},"institutions":[{"id":"https://openalex.org/I4210137149","display_name":"Renewable Energy Systems (United States)","ror":"https://ror.org/036gc1b60","country_code":"US","type":"company","lineage":["https://openalex.org/I4210090535","https://openalex.org/I4210137149"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Haobin Luo","raw_affiliation_strings":["RES Group Inc, Needham, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RES Group Inc, Needham, Massachusetts, USA","institution_ids":["https://openalex.org/I4210137149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058739959","display_name":"Lindsay B. Avery","orcid":"https://orcid.org/0000-0003-4920-8614","observed_orcids":["https://orcid.org/0000-0003-4920-8614"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lindsay B. Avery","raw_affiliation_strings":["DMPK, Sanofi, Waltham, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DMPK, Sanofi, Waltham, Massachusetts, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104110238","display_name":"Lindsay E. King","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lindsay E. King","raw_affiliation_strings":["BioMedicine Design, Pfizer Worldwide R&D, Andover, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMedicine Design, Pfizer Worldwide R&D, Andover, Massachusetts, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005706542","display_name":"Hendrik Neubert","orcid":"https://orcid.org/0000-0002-8476-5427","observed_orcids":["https://orcid.org/0000-0002-8476-5427"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hendrik Neubert","raw_affiliation_strings":["BioMedicine Design, Pfizer Worldwide R&D, Andover, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMedicine Design, Pfizer Worldwide R&D, Andover, Massachusetts, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047833194","display_name":"Hugh A. Barton","orcid":"https://orcid.org/0000-0002-9948-4724","observed_orcids":["https://orcid.org/0000-0002-9948-4724"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hugh A. Barton","raw_affiliation_strings":["BioMedicine Design, Pfizer Worldwide R&D, Groton, Connecticut, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMedicine Design, Pfizer Worldwide R&D, Groton, Connecticut, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011372088","display_name":"Alison M. Betts","orcid":"https://orcid.org/0000-0003-0848-3230","observed_orcids":["https://orcid.org/0000-0003-0848-3230"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alison M. Betts","raw_affiliation_strings":["BioMedicine Design, Pfizer Worldwide R&D, Cambridge, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMedicine Design, Pfizer Worldwide R&D, Cambridge, Massachusetts, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":null,"display_name":"Robert Webster","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Webster","raw_affiliation_strings":["BioMedicine Design, Pfizer Worldwide R&D, Cambridge, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMedicine Design, Pfizer Worldwide R&D, Cambridge, Massachusetts, USA","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5016745322"],"corresponding_institution_ids":["https://openalex.org/I180857899"],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":{"value":3000,"currency":"USD","value_usd":3000},"fwci":2.9079,"has_fulltext":true,"cited_by_count":52,"citation_normalized_percentile":{"value":0.91517178,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"8","issue":"10","first_page":"738","last_page":"747"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.9079999923706055},{"id":"https://openalex.org/keywords/physiologically-based-pharmacokinetic-model","display_name":"physiologically based pharmacokinetic modeling","score":0.9380000233650208},{"id":"https://openalex.org/keywords/fcrn","display_name":"neonatal Fc receptor","score":0.9570000171661377},{"id":"https://openalex.org/keywords/intracellular-trafficking","display_name":"intracellular trafficking","score":0.746999979019165},{"id":"https://openalex.org/keywords/allometric-scaling","display_name":"allometric scaling","score":0.6629999876022339},{"id":"https://openalex.org/keywords/ph-dependent-binding","display_name":"pH-dependent binding","score":0.7929999828338623},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.4480000138282776},{"id":"https://openalex.org/keywords/species-differences","display_name":"species differences","score":0.4830000102519989}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8403201103210449},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.6780561208724976},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.548508882522583},{"id":"https://openalex.org/C185867374","wikidata":"https://www.wikidata.org/wiki/Q2562769","display_name":"Physiologically based pharmacokinetic modelling","level":3,"score":0.5186473727226257},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5022103786468506},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3950933814048767},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3308935761451721},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.24271905422210693},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.09972512722015381},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07452473044395447}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006720","descriptor_name":"Homozygote","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008822","descriptor_name":"Mice, Transgenic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009928","descriptor_name":"Organ Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011961","descriptor_name":"Receptors, Fc","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D011961","descriptor_name":"Receptors, Fc","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D013045","descriptor_name":"Species Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015395","descriptor_name":"Histocompatibility Antigens Class I","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D015395","descriptor_name":"Histocompatibility Antigens Class I","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016014","descriptor_name":"Linear Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1002/psp4.12461","doi":"https://doi.org/10.1002/psp4.12461","is_oa":true,"landing_page_url":"https://doi.org/10.1002/psp4.12461","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/psp4.12461","source":{"id":"https://openalex.org/S4210231731","display_name":"CPT Pharmacometrics & Systems Pharmacology","issn_l":"2163-8306","issn":["2163-8306"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CPT: Pharmacometrics & Systems Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5783353","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6813168","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:31464379","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31464379","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CPT: pharmacometrics & systems pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6813168","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6813168/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CPT Pharmacometrics Syst Pharmacol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:c58bb5351c0144759f98b87e000c61f8","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/c58bb5351c0144759f98b87e000c61f8","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"CPT: Pharmacometrics & Systems Pharmacology, Vol 8, Iss 10, Pp 738-747 (2019)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1002/psp4.12461","doi":"https://doi.org/10.1002/psp4.12461","is_oa":true,"landing_page_url":"https://doi.org/10.1002/psp4.12461","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/psp4.12461","source":{"id":"https://openalex.org/S4210231731","display_name":"CPT Pharmacometrics & Systems Pharmacology","issn_l":"2163-8306","issn":["2163-8306"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CPT: Pharmacometrics & Systems Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2970050461.pdf","grobid_xml":"https://content.openalex.org/works/W2970050461.grobid-xml"},"referenced_works_count":42,"referenced_works":["https://openalex.org/W1547437295","https://openalex.org/W1555185942","https://openalex.org/W1966821331","https://openalex.org/W1967874097","https://openalex.org/W1968300672","https://openalex.org/W1970171471","https://openalex.org/W1992233783","https://openalex.org/W2002593667","https://openalex.org/W2002765161","https://openalex.org/W2011077241","https://openalex.org/W2011766387","https://openalex.org/W2021160162","https://openalex.org/W2051724555","https://openalex.org/W2054939724","https://openalex.org/W2056439160","https://openalex.org/W2057362015","https://openalex.org/W2074689515","https://openalex.org/W2093529351","https://openalex.org/W2101961850","https://openalex.org/W2114416030","https://openalex.org/W2116244572","https://openalex.org/W2129613538","https://openalex.org/W2136646559","https://openalex.org/W2140308459","https://openalex.org/W2142709610","https://openalex.org/W2146393360","https://openalex.org/W2151125872","https://openalex.org/W2169852145","https://openalex.org/W2196423560","https://openalex.org/W2324918890","https://openalex.org/W2338070486","https://openalex.org/W2400018431","https://openalex.org/W2473269993","https://openalex.org/W2515869346","https://openalex.org/W2578029714","https://openalex.org/W2608519759","https://openalex.org/W2776027284","https://openalex.org/W2798166211","https://openalex.org/W2915870000","https://openalex.org/W2936825025","https://openalex.org/W2969107478","https://openalex.org/W4388243180"],"related_works":["https://openalex.org/W4412952048","https://openalex.org/W7116738539","https://openalex.org/W4225246630","https://openalex.org/W2400018431","https://openalex.org/W2798166211","https://openalex.org/W4387569738","https://openalex.org/W2056439160","https://openalex.org/W7148687219","https://openalex.org/W3133679081","https://openalex.org/W3044346016"],"abstract_inverted_index":{"Monoclonal":[0],"antibody":[1],"(mAb)":[2],"pharmacokinetics":[3],"(PK)":[4],"have":[5,130],"largely":[6],"been":[7],"predicted":[8],"via":[9],"allometric":[10],"scaling":[11],"with":[12,64,146],"little":[13],"consideration":[14],"for":[15],"cross-species":[16],"differences":[17],"in":[18,47,60,77,115,141],"neonatal":[19],"Fc":[20],"receptor":[21],"(FcRn)":[22],"affinity":[23],"or":[24,136],"clearance/distribution":[25],"mechanisms.":[26],"To":[27],"address":[28],"this,":[29],"we":[30],"developed":[31],"a":[32,48,81,97],"mAb":[33,76],"physiologically-based":[34],"PK":[35,80,113,122,148],"model":[36,57,84,105],"that":[37],"describes":[38],"the":[39,87,93,121,142],"intracellular":[40],"trafficking":[41],"and":[42,54,71,123,138,149],"FcRn":[43,50,66,137],"recycling":[44],"of":[45,90,92,103,126,144],"mAbs":[46,94,127,145],"human":[49],"transgenic":[51],"homozygous":[52],"mouse":[53],"human.":[55],"This":[56],"uses":[58],"mAb-specific":[59],"vitro":[61,116],"data":[62,117],"together":[63],"species-specific":[65],"tissue":[67,69],"expression,":[68],"volume,":[70],"blood-flow":[72],"physiology":[73],"to":[74,108,129,133],"predict":[75,111],"vivo":[78],"linear":[79,112],"priori.":[82],"The":[83,100],"accurately":[85],"predicts":[86],"terminal":[88],"half-life":[89],"90%":[91],"investigated":[95],"within":[96],"twofold":[98],"error.":[99],"mechanistic":[101],"nature":[102],"this":[104],"allows":[106],"us":[107],"not":[109],"only":[110],"from":[114],"but":[118],"also":[119],"explore":[120],"target":[124,135],"binding":[125,132],"engineered":[128],"pH-dependent":[131],"its":[134],"could":[139],"aid":[140],"selection":[143],"optimal":[147],"pharmacodynamic":[150],"properties.":[151]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":14},{"year":2020,"cited_by_count":5}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2019-09-05T00:00:00"}